Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
European Journal of Pharmacology
|
February 1, 2025
Safety, tolerability and pharmacokinetic profile of the low-impact ampakine CX717 in young healthy male subjects and elderly healthy male and female subjects
Daniel P Radin, Rok Cerne, Jodi L Smith, et al.
Future Medicinal Chemistry
|
September 20, 2024
Preclinical characterization of a water-soluble low-impact ampakine prodrug, CX1942 and its active moiety, CX1763
Daniel P Radin, Sheng Zhong, Rok Cerne, et al.
Frontiers in Oncology
|
May 2, 2022
Lucanthone Targets Lysosomes to Perturb Glioma Proliferation, Chemoresistance and Stemness, and Slows Tumor Growth <i>In Vivo</i>
Daniel P Radin, Gregory Smith, Victoria Moushiaveshi, et al.
Current Alzheimer Research
|
February 11, 2025
Preclinical Pharmacology of CX1837, a High-Impact Ampakine with an Improved Safety Margin: Implications for Treating Alzheimer's Disease and Ischemic Stroke
Daniel P Radin, Sheng Zhong, Rok Cerne, et al.
Pharmacology, Biochemistry, and Behavior
|
February 2, 2025
Amplification of the therapeutic potential of AMPA receptor potentiators from the nootropic era to today
Daniel P Radin, Arnold Lippa, Sabhya Rana, et al.
Pharmacology & Therapeutics
|
November 9, 2024
Pharmacological modulation of respiratory control: Ampakines as a therapeutic strategy
Sabhya Rana, Anna F Fusco, Jeffrey M Witkin, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 31, 2024
Lucanthone, a Potential PPT1 Inhibitor, Perturbs Stemness, Reduces Tumor Microtube Formation, and Slows the Growth of Temozolomide-Resistant Gliomas In Vivo
Daniel P Radin, Sophie Shifman, Ian R Outhwaite, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
July 19, 2025
Targeting autophagy and plasminogen activator inhibitor-1 increases survival and remodels the tumor microenvironment in glioblastoma
Sophie G Shifman, Jennifer L O'Connor, Daniel P Radin, et al.
Biochemical Pharmacology
|
May 19, 2024
AMPA receptors play an important role in the biological consequences of spinal cord injury: Implications for AMPA receptor modulators for therapeutic benefit
Jeffrey M Witkin, Daniel P Radin, Sabhya Rana, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
European Journal of Pharmacology
|
February 1, 2025
Safety, tolerability and pharmacokinetic profile of the low-impact ampakine CX717 in young healthy male subjects and elderly healthy male and female subjects
Daniel P Radin, Rok Cerne, Jodi L Smith, et al.
Future Medicinal Chemistry
|
September 20, 2024
Preclinical characterization of a water-soluble low-impact ampakine prodrug, CX1942 and its active moiety, CX1763
Daniel P Radin, Sheng Zhong, Rok Cerne, et al.
Frontiers in Oncology
|
May 2, 2022
Lucanthone Targets Lysosomes to Perturb Glioma Proliferation, Chemoresistance and Stemness, and Slows Tumor Growth <i>In Vivo</i>
Daniel P Radin, Gregory Smith, Victoria Moushiaveshi, et al.
Current Alzheimer Research
|
February 11, 2025
Preclinical Pharmacology of CX1837, a High-Impact Ampakine with an Improved Safety Margin: Implications for Treating Alzheimer's Disease and Ischemic Stroke
Daniel P Radin, Sheng Zhong, Rok Cerne, et al.
Pharmacology, Biochemistry, and Behavior
|
February 2, 2025
Amplification of the therapeutic potential of AMPA receptor potentiators from the nootropic era to today
Daniel P Radin, Arnold Lippa, Sabhya Rana, et al.
Pharmacology & Therapeutics
|
November 9, 2024
Pharmacological modulation of respiratory control: Ampakines as a therapeutic strategy
Sabhya Rana, Anna F Fusco, Jeffrey M Witkin, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 31, 2024
Lucanthone, a Potential PPT1 Inhibitor, Perturbs Stemness, Reduces Tumor Microtube Formation, and Slows the Growth of Temozolomide-Resistant Gliomas In Vivo
Daniel P Radin, Sophie Shifman, Ian R Outhwaite, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
July 19, 2025
Targeting autophagy and plasminogen activator inhibitor-1 increases survival and remodels the tumor microenvironment in glioblastoma
Sophie G Shifman, Jennifer L O'Connor, Daniel P Radin, et al.
Biochemical Pharmacology
|
May 19, 2024
AMPA receptors play an important role in the biological consequences of spinal cord injury: Implications for AMPA receptor modulators for therapeutic benefit
Jeffrey M Witkin, Daniel P Radin, Sabhya Rana, et al.
Page
of 3